Cardiex Ltd Asset Resilience Ratio

Latest as of December 2024: 0.16%

Cardiex Ltd asset resilience ratio. Cardiex Ltd (CDX) has an Asset Resilience Ratio of 0.16% as of December 2024. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Cardiex Ltd (CDX) liquidity interval to measure how many days the company can operate on defensive assets alone.

Liquid Assets

AU$27.98K
≈ $19.80K USD Cash + Short-term Investments

Total Assets

AU$16.99 Million
≈ $12.02 Million USD All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio of Cardiex Ltd (2002–2024)

Asset resilience ratio of Cardiex Ltd from 2002 to 2024. This chart shows how Cardiex Ltd's Asset Resilience Ratio has changed over time. Read CDX liabilities breakdown for a breakdown of total debt and financial obligations.

Liquid Assets Composition Over Time

This chart breaks down Cardiex Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see balance sheet size of Cardiex Ltd.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents AU$0.00 0%
Short-term Investments AU$27.98K 0.16%
Total Liquid Assets AU$27.98K 0.16%

Asset Resilience Insights

  • Limited Liquidity: Cardiex Ltd maintains only 0.16% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company has significant short-term investments, indicating active treasury management.

Cardiex Ltd Industry Peers by Asset Resilience Ratio

Compare Cardiex Ltd's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223
Medical Devices 0.84%
Ningbo David Medical Device Co Ltd
SHE:300314
Medical Devices 5.11%
Affluent Medical SAS
PA:AFME
Medical Devices 0.03%
MODULIGHT OY EO 1
F:78W
Medical Devices 15.99%
DRGEM Corporation
KQ:263690
Medical Devices 2.12%
Nova EYE Medical Ltd
AU:EYE
Medical Devices 11.08%
Promimic AB
ST:PRO
Medical Devices 8.62%
Oncosil Medical Ltd
AU:OSL
Medical Devices 0.00%

Cardiex Ltd Asset Resilience Ratio by Year (2002–2024)

Cardiex Ltd asset resilience ratio by year from 2002 to 2024. The table below shows the annual Asset Resilience Ratio data for Cardiex Ltd.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2024-06-30 38.50% AU$4.87 Million
≈ $3.45 Million
AU$12.65 Million
≈ $8.95 Million
-0.36pp
2023-06-30 38.86% AU$5.56 Million
≈ $3.93 Million
AU$14.30 Million
≈ $10.12 Million
+30.43pp
2022-06-30 8.43% AU$1.04 Million
≈ $738.22K
AU$12.38 Million
≈ $8.76 Million
-5.20pp
2021-06-30 13.63% AU$1.54 Million
≈ $1.09 Million
AU$11.26 Million
≈ $7.97 Million
+6.81pp
2020-06-30 6.82% AU$728.54K
≈ $515.49K
AU$10.68 Million
≈ $7.55 Million
+46.59pp
2019-06-30 -39.77% AU$-5.25 Million
≈ $-3.72 Million
AU$13.21 Million
≈ $9.35 Million
--
2017-06-30 0.00% AU$0.00
≈ $0.00
AU$2.96 Million
≈ $2.09 Million
--
2016-06-30 0.00% AU$0.00
≈ $0.00
AU$4.60 Million
≈ $3.26 Million
--
2003-06-30 0.97% AU$15.00K
≈ $10.61K
AU$1.54 Million
≈ $1.09 Million
+0.01pp
2002-06-30 0.96% AU$15.00K
≈ $10.61K
AU$1.56 Million
≈ $1.10 Million
--
pp = percentage points

About Cardiex Ltd

AU:CDX Australia Medical Devices
Market Cap
$13.23 Million
AU$18.70 Million AUD
Market Cap Rank
#26182 Global
#1162 in Australia
Share Price
AU$0.03
Change (1 day)
+0.00%
52-Week Range
AU$0.03 - AU$0.03
All Time High
AU$2.74
About

Conneqt Health Limited engages in the design, manufacture, and marketing of medical devices used in cardiovascular health management in the Americas, Europe, and the Asia Pacific. It offers SphygmoCor, a vascular biometric technology that captures central hemodynamics and arterial stiffness for noninvasive measurement of vascular biomarkers including central aortic pressures and arterial stiffnes… Read more